$12.57
-0.70-5.28%
In chiusura: Nov 16, 4:00 PM EST
$12.19
-0.38-3.02%
Post-mercato: 5:17 PM EST

Kailera Therapeutics (KLRA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $-0.74 | $-1.12 | 33.9 % |
| Q2 | Aug 12, 2026 | $-1.09 | $-0.76 | -43.4 % |
| Q1 | May 26, 2026 | $-3.65 | $-0.55 | -563.6 % |
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Estimate | $-1.12 | $-0.76 | $-0.55 |
| Actual | $-0.74 | $-1.09 | $-3.65 |
| Surprise | +33.9% | -43.4% | -563.6% |
| Revenue | |||
| Estimate | — | — | — |
| Actual | $0 | $0 | $0 |
| Surprise | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.88 | $-0.86 | $-1.10 | $-1.14 |
| Revenue | ||||
| Consensus | — | — | — | — |